drugset

drugset / Trial / NCT00912145

To Demonstrate the Relative Bioavailability of Alprazolam Tablets, 2 mg

NCT00912145 ↗

Phase 1 Completed 26 enrolled Sandoz

RandomizedCrossoverOpen-labelTreatment

Summary

To Demonstrate the Relative Bioavailability of Alprazolam Tablets, 2 mg.

Timeline

Start: 1996-02
Primary completion: 1996-02
Completion: 1996-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Alprazolam	Small molecule	2 mg	—

Indications